retatrutide clinical trial us Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide for Weight Loss: TRIUMPH-1

Diabetes, 57, 20462054

Each patient was counted only once, at the date of their first prescription

Blood samples were collected from tail vein using heparinized capillary glass, and plasma glucose and insulin were determined by Wako Autokit glucose C2 (Wako) and insulin ELISA kit (Morinaga, Yokohama, Japan)

A lower dose of 0.25 - 1.0 mg is used for diabetes management

PlexusDx's Precision Peptide Genetic Test maps 14 distinct pathways and analyzes 150+ genetic insights across 49 peptides involved in weight regulation and metabolism

Keep your mental health provider and weight management doctor in close communication so both specialists understand your complete regimen